Literature DB >> 7836735

Change in blood pressure and 5-year risk of coronary heart disease among elderly men: the Finnish cohorts of the Seven Countries Study.

M Tervahauta1, J Pekkanen, H Enlund, A Nissinen.   

Abstract

OBJECTIVE: To study the association between blood pressure and change in blood pressure with future coronary risk among elderly men.
DESIGN: Cohort study.
SETTING: Finnish cohorts of the Seven Countries Study. PARTICIPANTS: Four hundred and seventy-six men aged 65-84 years and free of clinically manifested coronary heart disease at baseline, in 1984. MAIN OUTCOME MEASURES: Fatal myocardial infarction (n = 29), any myocardial infarction (n = 42), and incidence of any new signs and symptoms of coronary heart disease (n = 80) during a 5-year follow-up.
RESULTS: In multivariate analysis, a significant inverse U-shaped relationship was observed between baseline diastolic blood pressure and future fatal myocardial infarction, any myocardial infarction and any coronary heart disease. In models predicting the risk of coronary heart disease during 1984-1989, there was a significant interaction between both systolic (SBP) and diastolic blood pressure (DBP) in 1969-1974 and change in blood pressure between 1969-1974 and 1984. In categorical analyses, men (n = 42) who experienced a decline in DBP of > or = 4 mmHg from initial levels of > or = 90 mmHg had a higher risk of any myocardial infarction than men (n = 112) with a change of < 4 mmHg (odds ratio 4.5). For a decline of > or = 10 mmHg or more in SBP from levels of > or = 160 mmHg the corresponding odds ratio was 2.9. Men who experienced a decline in DBP or SBP from normotensive levels or an increase in blood pressure had no excess risk compared with men with stabile (change in DBP < 4 mmHg and change in SBP < 10 mmHg) blood pressure values.
CONCLUSION: The present results suggest that among elderly men a decline in DBP or SBP from previously hypertensive levels may be associated with increased coronary risk.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7836735

Source DB:  PubMed          Journal:  J Hypertens        ISSN: 0263-6352            Impact factor:   4.844


  10 in total

Review 1.  Conceptualisation and measurement of frailty in elderly people.

Authors:  K Rockwood; D B Hogan; C MacKnight
Journal:  Drugs Aging       Date:  2000-10       Impact factor: 3.923

Review 2.  The J-shaped Curve for Blood Pressure and Cardiovascular Disease Risk: Historical Context and Recent Updates.

Authors:  Faisal Rahman; John W McEvoy
Journal:  Curr Atheroscler Rep       Date:  2017-08       Impact factor: 5.113

Review 3.  Going Beyond the Guidelines in Individualising the Use of Antihypertensive Drugs in Older Patients.

Authors:  Ian A Scott; Sarah N Hilmer; David G Le Couteur
Journal:  Drugs Aging       Date:  2019-08       Impact factor: 3.923

Review 4.  The J-Curve Phenomenon in Hypertension.

Authors:  Yuan-Yuan Kang; Ji-Guang Wang
Journal:  Pulse (Basel)       Date:  2016-06-17

Review 5.  Inflammation, infection and atherosclerosis: do antibacterials have a role in the therapy of coronary artery disease?

Authors:  J L Mehta; F Romeo
Journal:  Drugs       Date:  2000-02       Impact factor: 9.546

6.  Association of Blood Pressure Trajectory With Mortality, Incident Cardiovascular Disease, and Heart Failure in the Cardiovascular Health Study.

Authors:  Christopher C Smitson; Rebecca Scherzer; Michael G Shlipak; Bruce M Psaty; Anne B Newman; Mark J Sarnak; Michelle C Odden; Carmen A Peralta
Journal:  Am J Hypertens       Date:  2017-06-01       Impact factor: 2.689

Review 7.  Tight blood pressure control in diabetes: evidence-based review of treatment targets in patients with diabetes.

Authors:  Gianpaolo Reboldi; Giorgio Gentile; Valeria Maria Manfreda; Fabio Angeli; Paolo Verdecchia
Journal:  Curr Cardiol Rep       Date:  2012-02       Impact factor: 2.931

8.  The significance of the j-curve in hypertension and coronary artery diseases.

Authors:  Chang Gyu Park; Ju Young Lee
Journal:  Korean Circ J       Date:  2011-07-30       Impact factor: 3.243

9.  Progression of conventional cardiovascular risk factors and vascular disease risk in individuals: insights from the PROG-IMT consortium.

Authors:  Martin Bahls; Matthias W Lorenz; Marcus Dörr; Lu Gao; Kazuo Kitagawa; Tomi-Pekka Tuomainen; Stefan Agewall; Gerald Berenson; Alberico L Catapano; Giuseppe D Norata; Michiel L Bots; Wiek van Gilst; Folkert W Asselbergs; Frank P Brouwers; Heiko Uthoff; Dirk Sander; Holger Poppert; Michael Hecht Olsen; Jean Philippe Empana; Ulf Schminke; Damiano Baldassarre; Fabrizio Veglia; Oscar H Franco; Maryam Kavousi; Eric de Groot; Ellisiv B Mathiesen; Liliana Grigore; Joseph F Polak; Tatjana Rundek; Coen DA Stehouwer; Michael R Skilton; Apostolos I Hatzitolios; Christos Savopoulos; George Ntaios; Matthieu Plichart; Stela McLachlan; Lars Lind; Peter Willeit; Helmuth Steinmetz; Moise Desvarieux; M Arfan Ikram; Stein Harald Johnsen; Caroline Schmidt; Johann Willeit; Pierre Ducimetiere; Jackie F Price; Göran Bergström; Jussi Kauhanen; Stefan Kiechl; Matthias Sitzer; Horst Bickel; Ralph L Sacco; Albert Hofman; Henry Völzke; Simon G Thompson
Journal:  Eur J Prev Cardiol       Date:  2019-10-16       Impact factor: 7.804

10.  Body mass index and change in blood pressure over a 7-year period in older Mexican Americans.

Authors:  Luis F Amador; Soham Al Snih; Kyriakos S Markides; James S Goodwin
Journal:  Clin Interv Aging       Date:  2006       Impact factor: 4.458

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.